Research and Development

Showing 15 posts of 9596 posts found.

Europe map

EMA readies paediatric trials network

May 14, 2010 Research and Development EMA, EMEA, paediatric, paediatric trials

The European Medicines Agency is about to press the start button on its long-planned network for clinical studies in children. …

Pfizer adds another product to its PAH franchise

May 14, 2010 Research and Development Ergonex, PAH, Pfizer, Thelin, revatio, terguride, viagra

Pfizer has signed an agreement to acquire terguride, a drug for pulmonary arterial hypertension (PAH) currently in phase II testing, …

Contract research news in brief

May 14, 2010 Research and Development CRO, Clinipace, Covance, Encorium, IR Pharma, Imperial College, PPD, Parexel

Developments in the contract research sector this week include the opening of new offices for Parexel and PPD, the spin-out …

Cedra appoints Anthony Busa

May 14, 2010 Research and Development CRO, Cedra, appointment, research and development

Phase I clinical trial specialist Cedra Corp division has appointed Anthony Busa as its new permanent chief executive, replacing acting …

WuXi posts buoyant increases in revenue and profit

May 13, 2010 Research and Development CRO, Charles River, Charles River Laboratories, WuXi

China’s WuXi PharmaTech has given would-be purchaser Charles River Laboratories a lift after posting buoyant increases in both revenues and …

Phillipe Lutz joins Telormedix

May 13, 2010 Research and Development appointment, research and development, telormedix

Swiss clinical stage biopharmaceutical company Telormedix has appointed Phillipe Lutz chief financial officer. He joins the company from Synosia Therapeutics, …

Kendle operating income slumps

May 13, 2010 Research and Development CRO, Kendle

US contract research organisation Kendle posted a 17% drop in revenues in the first quarter of 2010 to $90 million, …

Emerging markets key for Merck’s long-term performance

May 13, 2010 Research and Development, Sales and Marketing Merck & Co, em

Merck & Co has highlighted emerging markets such as China and Latin America as a major driver for its success …
Patrick-Vallance

GSK appoints Patrick Vallance

May 12, 2010 Research and Development GSK, appointment, research and development

Patrick Vallance has been appointed as senior vice president, medicines discovery and development at GlaxoSmithKline, and as a member of …

Synexus appoints Germany and Poland managers

May 11, 2010 Research and Development CRO, Synexus, appointment, research and development

Synexus has appointed Dr Helena Sigal as country manager for Germany and Radoslaw Janiak as country manager for Poland. Helena …

Calls for changes to trial publication process

May 11, 2010 Medical Communications, Research and Development industry relations, industry reputation, publication

Clinical trial publishing has not kept pace with changes in the way pharma carries out its research, according to a …

Crucell malaria vaccine starts trials in Africa

May 11, 2010 Research and Development Crucell, malaria

Dutch biopharma firm Crucell has started a phase I trial of its AdVac-based malaria vaccine in Burkina Faso, West Africa. …

Bayer colon cancer drug moves into phase III

May 11, 2010 Research and Development Bayer, colorectal cancer, regorafenib

Bayer Schering Pharma will shortly begin phase III tests of its investigational compound regorafenib for patients with metastatic colorectal cancer.  …

Merck gains rights to cancer treatment

May 10, 2010 Research and Development Ariad Pharmaceuticals, Merck & Co, NSCLC

Merck has acquired an exclusive license for a new cancer drug that’s in trials for a number of different forms …

Professor Sander van Deventer appointed to AMT supervisory board

May 10, 2010 Research and Development AMT, Amsterdam Molecular Therapeutics, appointment, research and development

Dutch human gene therapy company Amsterdam Molecular Therapeutics has appointed Professor Sander van Deventer to its supervisory board. One of …
The Gateway to Local Adoption Series

Latest content